在精神分裂症和双相情感障碍患者的多克隆IgG中出现蛋白质酶类催化活性
Rajendran Ramesh1, Aparna Sundaresh2, Ravi Philip Rajkumar3
1Centre for BioSeparation Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, 632014, India.
Scientific reports
|November 14, 2024
概括
这项研究在精神分裂症和双相情感障碍患者中发现血清IgG催化活性升高,这表明神经免疫功能障碍和重大精神病障碍中的潜在自身免疫联系.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 精神病学是一个精神病学.
背景情况:
- 神经免疫功能障碍和炎症与主要精神疾病有关.
- 血清IgG催化功能是精神疾病的潜在生物标志物.
研究的目的:
- 评估血清IgG蛋白酶类催化功能的精神分裂症和双相情感障碍.
- 为了比较精神病患者,健康对照者和神经精神病性狼患者之间的IgG活性.
主要方法:
- 使用特定的基质测量血清IgG催化活性.
- 显而易见的动力学数据被计算为酶活性.
- 参与者包括精神分裂症,双相情感障碍,神经精神病性狼患者和来自印度的健康对照.
主要成果:
- 精神分裂症患者的IgG活性比健康对照人高11倍.
- 双极性患者的IgG活性比狼患者高2.9倍,比健康对照患者高12倍.
- 神经精神病性狼患者的IgG活性比精神分裂症患者低2.7倍.
结论:
- 催化抗体存在于患有严重精神疾病的个体的血液中.
- 这些发现表明精神分裂症和双相情感障碍中的神经免疫功能障碍.
- 精神分裂症患者的一个子集可能具有自身免疫成分.
相关概念视频
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
473
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
473
Biological Causes of Schizophrenia
46
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
46
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
63
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
63
Positive Symptoms Schizophrenia: Hallucinations and Delusions
51
Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Hallucinations
Hallucinations in...
51
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K


